Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Les débuts de CRISPR en thérapie génique

1 Nov 2016

Abstract excerpt

Depuis l'apparition de la technique CRISPR-Cas9, qui s'est rpandue comme une trane de poudre dans les laboratoires de recherche, son emploi en thrapie gnique a souvent t voqu L'entreprise Editas, une des plus actives dans ce secteur, s'intresse notamment l'amaurose congnitale de Leber 1 , d'autres pathologies rtiniennes, mais aussi la mucoviscidose. Bien d'autres startup (CRISPR Therapeutics, Caribou Biosciences,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to CAR-T cell therapy research
Share to CRISPR and Genetic Engineering

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28008849
DOI: 10.1051/medsci/20163211024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Les débuts de CRISPR en thérapie géniquePMID 28008849Read ↗

Erratic journey of CRISPR/Cas9 in oncology from bench-work to successful-clinical therapySemantic proximity Read ↗

CRISPR/Cas9 Genome Editing in Oncology: Mechanisms, Therapeutic Platforms and Translational ChallengesSemantic proximity Read ↗

Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future ResearchSemantic proximity Read ↗

Harnessing the evolving CRISPR/Cas9 for precision oncologySemantic proximity Read ↗

CRISPR/Cas9: Role of genome editing in cancer immunotherapySemantic proximity Read ↗

Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and ChallengesSemantic proximity Read ↗

Precision Oncology in the CRISPR Era: Applications and Future Horizons in Cancer TherapySemantic proximity Read ↗

Precision Oncology in the CRISPR Era: Applications and Future Horizons in Cancer TherapySemantic proximity Read ↗

Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modelingSemantic proximity Read ↗

Next-generation diagnostics with CRISPRSemantic proximity Read ↗

Cancer: Can CRISPR Become a Game Changer?Semantic proximity Read ↗

The Potential Revolution of Cancer Treatment with CRISPR TechnologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.